Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 97-108 of 424
Drug study icon
RecruitingNCT07061288

Safety, Tolerability, and PK of an Injectable Form of KarXT

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Los Alamitos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT06894212

SEP-363856 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Japan.

Multiple locations, including Konan-shi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Japan
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Device study icon
RecruitingNCT07428460

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Verdun
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Drug study icon
RecruitingNCT04887792

Acetazolamide for Treatment Resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pittsburgh
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, India
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
RecruitingNCT06969755

Biomarkers to Enhance Early Schizophrenia Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States, Canada
Sponsor
Northwell Health
Condition
Schizophrenia
Device study icon
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionDeviceFrom 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia, Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.